SLC5A2 and hydrops fetalis: The “Guidelines for Diagnosis and Treatment of Heart Failurein China 2024” [8] recommend that patients with HF with a reduced ejectionfraction (HFrEF) should receive the “new quadruple” treatment scheme as soon aspossible with a small dose and incorporate SGLT2-Is into the original “goldentriangle” treatment.